Imperial College London
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Pre-oxygenation Methods in Bariatric Patients
Not Applicable
Completed
- Conditions
- ObesityAnesthesiaBariatric Surgery Candidate
- Interventions
- Device: Standard anaesthetic face maskDevice: Optiflow and THRIVE technique
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2019-10-18
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 80
- Registration Number
- NCT03428256
- Locations
- 🇬🇧
St Mary's Hospital, London, United Kingdom
The Acute Effects of Food Structure on Post Prandial Glucose and Subsequent Metabolic Responses
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Dietary Supplement: chickpea
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2021-04-02
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 15
- Registration Number
- NCT03424187
Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy
Phase 4
Recruiting
- Conditions
- Varicose Veins
- Interventions
- Drug: Foam sclerotherapyProcedure: Ambulatory phlebectomy
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 160
- Registration Number
- NCT03416413
- Locations
- 🇬🇧
Charing Cross Hospital, Imperial College London, London, United Kingdom
Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women
Phase 1
Completed
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Biological: Ad4-EnvCN54Biological: MVA-CN54Biological: CN54gp140/MPLA
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 68
- Registration Number
- NCT03408262
- Locations
- 🇬🇧
NIHR Imperial Clinical Research Facility, London, United Kingdom
Study of Pembrolizumab Following TACE in Primary Liver Carcinoma
Phase 1
Active, not recruiting
- Conditions
- Primary Liver Carcinoma
- Interventions
- Drug: PembrolizumabCombination Product: Trans-arterial chemoembolization
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 26
- Registration Number
- NCT03397654
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
Mechanochemical Ablation Compared to Cyanoacrylate Adhesive
Not Applicable
Completed
- Conditions
- Varicose Veins
- Interventions
- Procedure: Cyanoacrylate adhesiveProcedure: Mechanochemical ablation
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2022-08-04
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 167
- Registration Number
- NCT03392753
- Locations
- 🇬🇧
Charing Cross Hospital, Imperial College London, London, United Kingdom
Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy
Not Applicable
Completed
- Conditions
- Biliary ColicCholecystitis
- Interventions
- Procedure: Laparoscopic CholecystectomyDevice: Senhance Assisted Cholecystectomy
- First Posted Date
- 2017-12-21
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 40
- Registration Number
- NCT03380572
- Locations
- 🇬🇧
Imperial College NHS Trust, London, United Kingdom
Resection of the Esophagus and Subsequent Weight Loss
Terminated
- Conditions
- Esophageal CancerWeight GainEating BehaviorFood Reward
- Interventions
- Other: Clinical treatment
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 30
- Registration Number
- NCT03377660
- Locations
- 🇮🇪
Conway Institute, UCD, Dublin, Ireland
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT03371862
- Locations
- 🇬🇧
St Mark's Hospital, Harrow, United Kingdom
Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers
Phase 4
Completed
- Conditions
- Anaphylaxis
- Interventions
- Combination Product: Epipen 0.3mgCombination Product: Emerade 300mcgCombination Product: Emerade 500mcg
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 12
- Registration Number
- NCT03366298
- Locations
- 🇬🇧
Imperial College London / Imperial College Healthcare NHS Trust, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath